Real world assessment of SARS-CoV-2 nasopharyngeal swab testing in a high burden COVID-19 region.

Concerns persist regarding possible false negative results that may compromise COVID-19 containment. While obtaining a true false negative rate is infeasible, using real world observation these data suggest a possible false negative rate to be approximately 2.3%. Use of a sensitive, amplified RNA platform should reassure healthcare systems.